Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0K8YX
|
|||
Drug Name |
4SCAR19 and 4SCAR30
|
|||
Drug Type |
CAR T Cell Therapy (Dual specific)
|
|||
Indication | B-cell lymphoma [ICD-11: 2A86; ICD-10: C85.1; ICD-9: 202.8] | Phase 1/2 | [1] | |
Company |
Shenzhen Geno-Immune Medical Institute
|
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT03125577) Combination CAR-T Cell Therapy Targeting Hematological Malignancies |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.